At a glance
ClinicalIndex Comparison RecordN/ACompleted· 20 enrolled
Drug / intervention
EXPLORER PET/CTdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
EXPLORER PET/CT: Evaluation of Healthy Individuals From Racial/Ethnic Minority Populations
In Brief
A clinical study evaluating EXPLORER PET/CT for Healthy Volunteers From Racial/Ethnic Minority Populations. Completed, enrolled 20 participants across 1 site.
Detailed Summary
The objective of this pilot study is to collect preliminary data using total body scans on a new, first of its kind, FDA 510k-cleared positron emission tomography/computed tomography (PET/CT) scanner, called EXPLORER. The study will aim to recruit healthy individuals from racial/ethnic minority populations.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
First PostedMar 2021
Enrollment StartAug 2021
Primary CompletionNov 2021
TodayJul 2026
First PostedMar 23, 2021
Enrollment StartAug 18, 2021
Primary CompletionNov 8, 2021
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 5.3 years ago
Interventions
EXPLORER PET/CTdevice
FDG PET Scans on the total body EXPLORER PET/CT scanner